Terms: = Sarcomas AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Diagnosis
11 results:
1. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
[TBL] [Abstract] [Full Text] [Related]
2. Comparison between Fluorescence in-situ Hybridization (FISH), Reverse Transcriptase PCR (RT-PCR) and fragment analysis, for detection of t (X; 18) (p11; q11) translocation in synovial sarcomas.
Shetty O; Pai T; Gurav M; Rekhi B
Indian J Pathol Microbiol; 2020; 63(1):64-72. PubMed ID: 32031125
[TBL] [Abstract] [Full Text] [Related]
3. Spindle Cell Melanoma and Interdigitating Dendritic Cell Sarcoma: Do They Represent the Same Process?
Stowman AM; Mills SE; Wick MR
Am J Surg Pathol; 2016 Sep; 40(9):1270-9. PubMed ID: 27299798
[TBL] [Abstract] [Full Text] [Related]
4. Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning.
Olstad OK; Gautvik VT; Reppe S; Rian E; Jemtland R; Ohlsson C; Bruland OS; Gautvik KM
Anticancer Res; 2003; 23(3B):2201-16. PubMed ID: 12894494
[TBL] [Abstract] [Full Text] [Related]
5. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.
Bacci G; Briccoli A; Ferrari S; Longhi A; Mercuri M; Capanna R; Donati D; Lari S; Forni C; DePaolis M
Eur J Cancer; 2001 Nov; 37(16):2030-9. PubMed ID: 11597381
[TBL] [Abstract] [Full Text] [Related]
6. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
Bacci G; Ferrari S; Delepine N; Bertoni F; Picci P; Mercuri M; Bacchini P; Brach del Prever A; Tienghi A; Comandone A; Campanacci M
J Clin Oncol; 1998 Feb; 16(2):658-63. PubMed ID: 9469355
[TBL] [Abstract] [Full Text] [Related]
7. Secondary acute non-lymphoblastic leukemia in two children following treatment with a cis-diamminedichloroplatinum-II-based regimen for osteosarcoma.
Jeha S; Jaffe N; Robertson R
Med Pediatr Oncol; 1992; 20(1):71-4. PubMed ID: 1727215
[TBL] [Abstract] [Full Text] [Related]
8. Increased survival, limb preservation, and prognostic factors for osteosarcoma.
Petrilli AS; Gentil FC; Epelman S; Lopes LF; Bianchi A; Lopes A; Figueiredo MT; Marques E; De Bellis N; Consentino E
Cancer; 1991 Aug; 68(4):733-7. PubMed ID: 1855172
[TBL] [Abstract] [Full Text] [Related]
9. Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival.
Jaffe N; Spears R; Eftekhari F; Robertson R; Cangir A; Takaue Y; Carrasco H; Wallace S; Ayala A; Raymond K
Cancer; 1987 Feb; 59(4):701-9. PubMed ID: 3492261
[TBL] [Abstract] [Full Text] [Related]
10. Control of primary osteosarcoma with chemotherapy.
Jaffe N; Robertson R; Takaue Y; Cangir A; Wallace S; Carrasco H; Eftekhari F; Ayala A; Wang A
Cancer; 1985 Aug; 56(3):461-6. PubMed ID: 3873985
[TBL] [Abstract] [Full Text] [Related]
11. Computed tomography of osteosarcoma after intraarterial chemotherapy.
Shirkhoda A; Jaffe N; Wallace S; Ayala A; Lindell MM; Zornoza J
AJR Am J Roentgenol; 1985 Jan; 144(1):95-9. PubMed ID: 3871155
[TBL] [Abstract] [Full Text] [Related]
